- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Genomic Valley Biotech Limited has announced that its share transfer agent confirmed compliance with all procedures for dematerialization during the quarter ending December 2025. This means physical shares submitted for conversion into electronic form were duly processed, confirmed with depositories, and listed on stock exchanges. The company's records were updated, with physical certificates cancelled and depositories registered as owners within 15 days, ensuring smooth and accurate shareholding management for investors.